Description
Have you got patients with hypothyroid symptoms but normal results? Or results that suggest the HPT axis just seems to be broken? Could it be the result of a combination of Endocrine Disrupting Chemicals (EDCs)? How do you assess for these ‘new goitrogens’, which act more potently and more insidiously, inducing hypothyroidism ‘without a trace’. How do you maximise prevention for all of your clients and the most at risk sub-populations or minimise impact for those already in the full grip of their consequences.
This audio comes with 3 key related scientific articles and a bonus larger powerpoint presentation that Rachel presented at ASLM Conference in Sydney.
Did you know you can subscribe to these? We deliver at the end of each month, just add a 12 month subscription to your cart and Rachel’s latest research is on its way to you!
